Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

289.92 -3.77 (-1.29%)
Streaming Delayed Price Updated: 9:37 AM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bio-Rad Laboratories, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Why a Fund Trimmed a $41 Million CompoSecure Stake Amid a 47% Stock Run ↗
Amid a monster year and, more recently, a transformative deal announcement, this move raises a sharper question about how much upside is really left at today’s valuation. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Earnings Scheduled For October 29, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For July 31, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 1, 2025 ↗
 
Via Benzinga
News headline image
A Preview Of Bio-Rad Laboratories's Earnings ↗
 
Via Benzinga
News headline image
Why a Fund Cut $4 Million of Payoneer Stock Despite Record Revenues ↗
Payoneer just posted record revenue and raised guidance, yet one fund trimmed its stake. The disconnect is where the real story is. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday ↗
The company doesn't seem like it will generate pops in key fundamentals anytime soon. 
Via The Motley Fool
Topics Supply Chain
News headline image
Bio-Rad Reports Third-Quarter 2025 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
Thermo Fisher Scientific Inc. (NYSE: TMO) experienced a robust surge in its stock value today, October 1, 2025, climbing an impressive 9.79% as market optimism swelled around a series of recent... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad's Management to Participate in Upcoming Investor Conferences
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad (BIO) Q2 EPS Jumps 51% ↗
Via The Motley Fool
News headline image
Bio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings ↗
 
Via Benzinga
News headline image
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
These stocks are moving in today's after hours session ↗
Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
News headline image
Bio-Rad Reports Second-Quarter 2025 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
5 Analysts Have This To Say About Bio-Rad Laboratories ↗
 
Via Benzinga
News headline image
Bio-Rad’s Management to Host Investor Meetings During Jefferies Global Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Bio-Rad Reports First-Quarter 2025 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer (aNSCLC) was supported by Biodesix, using Bio-Rad Droplet Digital™ PCR technology 
From Biodesix, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.